Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer

  1. Lara, P.C.
  2. Rodríguez-Melcón, J.I.
  3. Palacios-Eito, A.
  4. Lozano, A.
  5. Hervás-Morón, A.
  6. Villafranca, E.
  7. Gómez-Iturriaga, A.
  8. Sancho, G.
  9. Maldonado, X.
Journal:
Frontiers in Oncology

ISSN: 2234-943X

Year of publication: 2022

Volume: 12

Type: Article

DOI: 10.3389/FONC.2022.891886 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals